NCIt definition : A second-generation, orally bioavailable dual kinase inhibitor with potential antineoplastic
activity. EGFR/HER2 inhibitor AV-412 binds to and inhibits the epidermal growth factor
receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2), which may
result in the inhibition of tumor growth and angiogenesis, and tumor regression in
EGFR/HER2-expressing tumors. This agent may be active against EGFR/HER2-expressing
tumor cells that are resistant to first-generation kinase inhibitors. EGFR and HER2
are receptor tyrosine kinases that play major roles in tumor cell proliferation and
tumor vascularization.;
UNII : Z541VW0W40;
InChIKey : GTWJVFFZCKODEV-UHFFFAOYSA-N;
CAS number : 451493-31-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 451493-31-5
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;